Olema Oncology
The Associate Director of Analytical Development at Olema Oncology leads analytical method development, validation, and technical review for drug substances and products, supporting regulatory filings and cross-functional collaboration in a fast-paced biotech environment.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2007
Olema Oncology is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel targeted therapies for metastatic breast cancer and beyond. The company leverages its deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance to advance its pipeline, including Phase 3 breast cancer trials and a KAT6 inhibitor program being evaluated in solid tumors and prostate cancer. Founded in 2006 and headquartered in San Francisco, California, Olema trades on Nasdaq under the ticker OLMA.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Olema Oncology.
44% above the average for this role
Olema Oncology to Present at the TD Cowen 46th Annual Health Care Conference
3 weeks ago
Senior Scientist, Analytical Development and Quality Control (Drug Product)
Nurix
Director, Analytical Development (Small Molecule)
Structure Therapeutics
Analytical Scientist
Bora Pharmaceuticals
Analytical Development Lead
Relay Therapeutics
Principal Scientist to Associate Director, Analytical Development
Structure Therapeutics
Director, Analytical Services
Harrow, Inc.